UnitedHealth Group Inc. (NYSE:UNH)

The segment profit margin for UnitedHealthcare exhibited a generally increasing trend from 2021 to 2023, followed by a significant decline in 2024 and a partial recovery in 2025. This movement is accompanied by consistent growth in both earnings before income taxes and revenues over the period, though the rate of growth varies.

Segment Profit Margin Trend

The segment profit margin increased from 5.37% in 2021 to 5.83% in 2023, indicating improving profitability relative to revenue. However, a substantial decrease to 2.44% occurred in 2024. The margin then experienced a modest increase to 2.66% in 2025, but remained significantly below the levels observed in the preceding three years.

Revenue Growth

Revenues demonstrated consistent year-over-year growth throughout the analyzed period. Revenue increased from US$222,899 million in 2021 to US$344,903 million in 2025. The largest absolute increase in revenue occurred between 2024 and 2025, with an increase of US$46,700 million. However, the rate of revenue growth slowed in 2024 compared to 2022 and 2023.

Earnings Before Income Taxes

Earnings before income taxes also increased from 2021 to 2023, rising from US$11,975 million to US$16,415 million. A considerable decline was observed in 2024, falling to US$7,274 million, before partially recovering to US$9,160 million in 2025. The decrease in earnings before income taxes in 2024 aligns with the significant drop in segment profit margin.

The divergence between revenue growth and profit margin in 2024 suggests potential factors impacting profitability, such as increased costs, changes in pricing strategies, or shifts in the revenue mix. While revenues continued to rise, the substantial reduction in earnings before income taxes and the corresponding decrease in segment profit margin indicate a weakening of profitability during that year. The partial recovery in 2025 suggests some mitigation of these factors, but the profit margin remains below prior levels.

The segment profit margin for Optum Health exhibited a fluctuating pattern over the five-year period. Initially, earnings before income taxes and revenues demonstrated positive growth, which translated into a generally improving profit margin. However, more recent periods reveal a significant shift in performance.

Profit Margin Trend

The segment profit margin increased from 8.25% in 2021 to 8.48% in 2022, indicating improved profitability relative to revenue. A subsequent decline was observed in 2023, with the margin falling to 6.88%. While a modest recovery occurred in 2024, reaching 7.37%, this was followed by a substantial decrease in 2025, resulting in a negative profit margin of -0.27%.

Revenue and Earnings Relationship

Revenues, including investment and other income, consistently increased from $54,065 million in 2021 to $105,358 million in 2024. However, this revenue growth did not consistently translate into proportional earnings growth. While earnings before income taxes increased alongside revenue through 2024, reaching $7,770 million, they experienced a dramatic decline in 2025, reporting a loss of -$278 million. This divergence is a primary driver of the negative segment profit margin in the final year.

The period between 2021 and 2024 showed a relatively stable, albeit modestly improving, profit margin. The substantial shift in 2025, characterized by declining earnings despite relatively stable revenues, warrants further investigation to determine the underlying causes. The negative profit margin in 2025 represents a significant departure from prior performance and suggests potential challenges within the Optum Health segment.

The segment experienced fluctuating financial performance between 2021 and 2025. Revenues demonstrated consistent growth over the period, while earnings before income taxes exhibited a more volatile pattern. This resulted in a declining segment profit margin.

Revenue Trend

Revenues increased from US$12.199 billion in 2021 to US$19.417 billion in 2025, representing a cumulative growth of 58.8%. Growth was particularly strong between 2021 and 2023, slowing somewhat in the subsequent two years. The increase from 2023 to 2024 was minimal, and a slight increase was observed from 2024 to 2025.

Earnings Before Income Taxes Trend

Earnings before income taxes initially increased from US$3.398 billion in 2021 to US$4.268 billion in 2023, a growth of 25.6%. However, a significant decrease was then observed, falling to US$3.097 billion in 2024 and further to US$2.624 billion in 2025. This represents a cumulative decline of 38.7% from the 2023 peak.

Segment Profit Margin Trend

The segment profit margin decreased steadily throughout the analyzed period. Starting at 27.85% in 2021, it declined to 13.51% in 2025. The most substantial decrease occurred between 2023 and 2024, dropping from 22.54% to 16.51%. The rate of decline slowed between 2024 and 2025, but the overall trend remains downward. This suggests that while revenues are growing, the segment is becoming less efficient at converting those revenues into profit.

The divergence between revenue growth and declining profitability warrants further investigation. Potential factors contributing to this trend could include increased operating costs, changes in pricing strategies, or shifts in the revenue mix towards lower-margin services.

The segment experienced consistent revenue growth over the five-year period. Earnings before income taxes also demonstrated a positive trend, increasing year-over-year. However, the segment profit margin exhibited a more nuanced pattern, initially declining before recovering in the final year.

Revenue Trend

Revenues increased from US$91.314 billion in 2021 to US$154.726 billion in 2025. This represents a cumulative growth of approximately 69.4% over the period. The rate of revenue growth accelerated from 9.2% between 2021 and 2022 to 16.4% between 2023 and 2024, before moderating to 16.1% between 2024 and 2025.

Earnings Before Income Taxes Trend

Earnings before income taxes increased from US$4.135 billion in 2021 to US$7.193 billion in 2025, a cumulative increase of 73.8%. The growth rate in earnings generally tracked the revenue growth, with increases of 7.5%, 15.2%, 13.9%, and 23.4% year-over-year, respectively.

Segment Profit Margin Trend

The segment profit margin began at 4.53% in 2021 and decreased to 4.38% in 2024. This indicates a period of margin compression despite revenue and earnings growth. However, the profit margin rebounded to 4.65% in 2025, suggesting improved operational efficiency or pricing power in the latest year. The initial decline may be attributable to increased costs or competitive pressures, while the 2025 increase could reflect economies of scale or successful cost management initiatives.

Overall, the segment demonstrated strong financial performance with consistent growth in both revenue and earnings. The temporary decline and subsequent recovery in the segment profit margin warrant further investigation to understand the underlying drivers and ensure sustained profitability.

The segment Return on Assets (ROA) for UnitedHealthcare demonstrates a generally positive trajectory from 2021 to 2023, followed by a significant decline in 2024 and a partial recovery in 2025. This analysis details the observed trends in segment ROA alongside its underlying components, Earnings before Income Taxes and Total Assets.

Earnings before Income Taxes

Earnings before income taxes increased steadily from US$11,975 million in 2021 to US$16,415 million in 2023, representing a cumulative growth of approximately 37.0%. However, a substantial decrease occurred in 2024, falling to US$7,274 million, before partially recovering to US$9,160 million in 2025. This volatility in earnings significantly influences the segment’s ROA.

Total Assets

Total assets exhibited consistent growth throughout the analyzed period. From US$102,967 million in 2021, assets increased to US$124,051 million in 2025, representing a cumulative increase of approximately 20.5%. The consistent growth in asset base, coupled with the fluctuating earnings, impacts the overall ROA.

Segment ROA

Segment ROA increased from 11.63% in 2021 to 14.80% in 2023, indicating improved profitability relative to the asset base. The ROA experienced a sharp decline in 2024, dropping to 6.11%, primarily driven by the significant reduction in earnings before income taxes. A modest recovery to 7.38% was observed in 2025, coinciding with the partial rebound in earnings. The 2024 decline suggests a potential decrease in the efficiency with which assets are being utilized to generate earnings within this segment.

The correlation between Earnings before Income Taxes and Segment ROA is strong. The substantial decrease in earnings in 2024 directly resulted in the lowest ROA observed during the period. While assets continued to grow, the inability to translate that asset base into commensurate earnings negatively impacted the segment’s performance. The partial recovery in 2025 suggests a potential stabilization, but further monitoring is warranted to assess the sustainability of this trend.

The segment Return on Assets (ROA) for Optum Health exhibited a generally positive trend from 2021 to 2024, followed by a significant decline in 2025. This analysis details the observed patterns in segment ROA alongside its underlying components, Earnings before Income Taxes and Total Assets.

Earnings before Income Taxes

Earnings before income taxes demonstrated consistent growth from 2021 to 2024, increasing from US$4,462 million to US$7,770 million. However, a substantial decrease occurred in 2025, resulting in a loss of US$278 million. This represents a dramatic shift in profitability for the segment.

Total Assets

Total assets within Optum Health consistently increased throughout the observed period. Growth progressed from US$60,474 million in 2021 to US$100,991 million in 2025. This indicates ongoing investment and expansion within the segment, despite the eventual decline in profitability.

Segment ROA

Segment ROA initially increased from 7.38% in 2021 to 8.75% in 2022, reflecting improved profitability relative to asset base. A slight decrease to 7.34% was observed in 2023, followed by a recovery to 8.05% in 2024. The ROA experienced a sharp decline in 2025, falling to -0.28%. This negative value signifies that the segment’s assets generated a loss rather than a profit during that year. The decline in ROA in 2025 is directly attributable to the significant decrease in Earnings before Income Taxes, despite the continued growth in Total Assets.

The sustained asset growth coupled with the substantial earnings decline in 2025 suggests a potential issue with asset utilization or operational efficiency within Optum Health during that period. Further investigation into the factors contributing to the 2025 loss is warranted.

The segment’s earnings before income taxes exhibited an initial increase followed by a decline over the five-year period. Earnings rose from US$3,398 million in 2021 to US$4,268 million in 2023, before decreasing to US$2,624 million in 2025. Total assets demonstrated substantial growth between 2021 and 2023, increasing from US$16,868 million to US$34,173 million, and then stabilized with modest increases in subsequent years, reaching US$35,400 million in 2025.

Segment Return on Assets (ROA)

Segment ROA experienced a significant decrease over the observed period. Starting at 20.14% in 2021, it declined to 7.41% in 2025. The most substantial decrease occurred between 2021 and 2022, falling to 11.54%. While a slight recovery was noted in 2023, reaching 12.49%, the downward trend resumed, with ROA decreasing to 8.99% in 2024 and further to 7.41% in 2025. This suggests a diminishing ability to generate earnings relative to the segment’s asset base.

The divergence between asset growth and earnings performance is notable. While total assets increased considerably, particularly in the earlier years, earnings did not maintain a corresponding upward trajectory. This discrepancy is reflected in the declining ROA, indicating that the segment’s investments in assets are generating progressively lower returns. The stabilization of assets in the later years does not appear to have arrested the decline in profitability, as evidenced by the continued decrease in segment ROA.

The decrease in earnings before income taxes from 2023 to 2025, coupled with the relatively stable asset base, is the primary driver of the observed ROA decline. Further investigation would be required to determine the underlying causes of the earnings decrease, such as changes in revenue, cost structure, or operational efficiency.

The segment’s earnings before income taxes exhibited a consistent upward trajectory over the five-year period. Beginning at US$4,135 million in 2021, earnings increased to US$7,193 million in 2025. Total assets also demonstrated growth throughout the period, rising from US$40,181 million in 2021 to US$62,262 million in 2025.

Segment Return on Assets (ROA)

Segment ROA experienced initial fluctuation before demonstrating an overall positive trend. In 2021, the segment ROA was 10.29%. A decrease was observed in 2022, with ROA falling to 9.34%. The following year, 2023, saw a recovery to 9.98%, and this level was sustained in 2024 at 9.88%. A notable increase in segment ROA occurred in 2025, reaching 11.55%, the highest value observed during the analyzed period. This suggests improving efficiency in asset utilization in generating earnings towards the end of the period.

The growth in both earnings and assets indicates expansion within the segment. The initial dip in ROA in 2022, followed by stabilization and subsequent improvement, suggests that while asset growth outpaced earnings growth temporarily, the segment ultimately improved its ability to generate profits from its asset base. The substantial ROA increase in 2025 warrants further investigation to understand the drivers behind this performance.

The UnitedHealthcare segment demonstrates a consistent upward trend in revenue generation alongside moderate growth in total assets over the observed five-year period. This has resulted in a strengthening segment asset turnover ratio, indicating increasing efficiency in asset utilization.

Revenues

Revenues, including investment and other income, experienced consistent year-over-year growth, increasing from US$222,899 million in 2021 to US$344,903 million in 2025. The rate of growth appears to have accelerated in the later years of the period, with a more substantial increase between 2023 and 2025 than earlier periods.

Total Assets

Total assets within the UnitedHealthcare segment also increased steadily, moving from US$102,967 million in 2021 to US$124,051 million in 2025. However, the growth in assets was less pronounced than the growth in revenues, suggesting improved asset management.

Segment Asset Turnover

The segment asset turnover ratio, a measure of how efficiently assets are used to generate revenue, exhibited a clear increasing trend. Starting at 2.16 in 2021, the ratio rose to 2.78 in 2025. While there was a slight dip from 2.54 in 2023 to 2.51 in 2024, the overall trajectory indicates improved operational efficiency. This suggests that the segment is becoming more effective at converting its investments in assets into sales revenue.

The consistent growth in revenue coupled with a rising asset turnover ratio suggests effective management of resources within the UnitedHealthcare segment. The segment is demonstrating an increasing ability to generate sales from its asset base, which is a positive indicator of financial performance.

The segment asset turnover for Optum Health demonstrates a generally positive trend from 2021 to 2024, followed by a slight decrease in the most recent year. Revenues exhibited consistent growth throughout the period, while total assets also increased, though at a somewhat slower pace in the final year examined.

Segment Asset Turnover

The segment asset turnover ratio increased from 0.89 in 2021 to 1.09 in 2024, indicating improving efficiency in asset utilization to generate revenue. This suggests Optum Health became increasingly effective at converting its investments in assets into sales during this timeframe. However, the ratio decreased to 1.01 in 2025, representing a slight reduction in efficiency. This decrease warrants further investigation to determine the underlying causes.

Revenue Trend

Revenues experienced substantial growth, increasing from US$54,065 million in 2021 to US$105,358 million in 2024. While growth continued into 2025, the rate of increase slowed, with revenues reaching US$101,957 million. This deceleration in revenue growth may be a contributing factor to the observed decrease in asset turnover in 2025.

Asset Trend

Total assets increased consistently from US$60,474 million in 2021 to US$96,472 million in 2024. The rate of asset growth slowed in 2025, with total assets reaching US$100,991 million. The slower asset growth in 2025, coupled with the deceleration in revenue growth, likely contributed to the slight decline in the segment asset turnover ratio.

Overall, Optum Health demonstrated improving asset utilization from 2021 to 2024. The slight decrease in segment asset turnover in 2025, coinciding with slower growth in both revenues and assets, suggests a potential shift in operational efficiency that merits further scrutiny.

The segment performance of Optum Insight reveals fluctuating revenue alongside increasing total assets over the five-year period. Analysis of the segment asset turnover ratio indicates a declining efficiency in asset utilization initially, followed by a period of relative stabilization.

Revenues

Revenues experienced consistent growth from 2021 to 2023, increasing from US$12,199 million to US$18,932 million. This growth slowed in 2024, with revenues decreasing to US$18,757 million, before resuming a modest increase to US$19,417 million in 2025. The rate of revenue expansion decelerated in the latter part of the period.

Total Assets

Total assets demonstrated a substantial increase from US$16,868 million in 2021 to US$35,400 million in 2025. The most significant increase occurred between 2021 and 2022, with asset growth slowing in subsequent years, though remaining positive. This suggests continued investment in the segment, but at a diminishing rate.

Segment Asset Turnover

The segment asset turnover ratio decreased from 0.72 in 2021 to 0.47 in 2022, indicating a reduced ability to generate revenue from its asset base. The ratio partially recovered to 0.55 in 2023 and remained relatively stable at 0.54 and 0.55 in 2024 and 2025, respectively. While the ratio did not return to its 2021 level, the stabilization suggests that the initial decline in asset utilization may have been addressed, or that the rate of decline has slowed. The consistent asset growth alongside a stable turnover ratio implies that new assets are being deployed at a similar efficiency to the existing asset base.

In summary, Optum Insight experienced revenue growth alongside significant asset accumulation. The initial decline in asset turnover warrants attention, but the subsequent stabilization suggests potential mitigation of the initial efficiency loss. Continued monitoring of both revenue growth and asset turnover is recommended to assess the long-term sustainability of asset utilization within the segment.

The segment experienced consistent revenue growth over the five-year period. Total assets also increased, though at a slightly more moderate pace. Analysis of the segment asset turnover reveals a generally stable performance with a notable increase in the most recent year.

Segment Asset Turnover

The segment asset turnover ratio decreased from 2.27 in 2021 to 2.10 in 2022, indicating a slight reduction in the efficiency of asset utilization in generating revenue. This was followed by a recovery, with the ratio increasing to 2.26 in 2023 and remaining relatively stable at 2.25 in 2024. A significant increase to 2.49 is observed in 2025, suggesting improved efficiency in asset utilization during that year.

The initial decline in 2022 may be attributable to faster asset growth compared to revenue growth. The subsequent stabilization and then increase in the ratio suggest that revenue generation began to more effectively leverage the asset base. The substantial increase in 2025 warrants further investigation to determine the underlying drivers, such as operational improvements or changes in asset composition.

Overall, the segment demonstrates a positive trend in revenue generation alongside increasing asset levels. The asset turnover ratio, while experiencing a minor dip, ultimately shows improvement, particularly in the final year of the observed period, indicating enhanced operational efficiency.

Analysis of segment capital expenditures to depreciation for the observed period reveals a generally increasing trend. Purchases of property, equipment, and capitalized software demonstrate relative stability, while depreciation and amortization exhibit a slight decline over the five-year period. This interplay drives the observed changes in the segment capital expenditures to depreciation ratio.

Purchases of Property, Equipment and Capitalized Software

Expenditures on property, equipment, and capitalized software remained relatively consistent between 2021 and 2023, fluctuating between US$795 million and US$866 million. A slight decrease to US$781 million was noted in 2024, followed by a modest increase to US$816 million in 2025. This suggests a consistent level of investment in maintaining and modestly expanding operational capacity.

Depreciation and Amortization

Depreciation and amortization decreased from US$1,004 million in 2021 to US$973 million in 2022. It experienced a slight recovery to US$989 million in 2023, but then declined further to US$889 million in 2024 and remained at US$883 million in 2025. This decline may indicate a maturing asset base or changes in the method of asset valuation.

Segment Capital Expenditures to Depreciation

The segment capital expenditures to depreciation ratio increased steadily from 0.79 in 2021 to 0.92 in 2025. The ratio remained stable at 0.88 in both 2023 and 2024. This upward trend suggests that capital expenditures are increasingly covering a larger portion of the depreciation expense, potentially indicating a shift towards more capital-intensive operations or a slower rate of asset depreciation relative to new investments. The consistency in 2023 and 2024 suggests a temporary stabilization before resuming the upward trajectory.

In summary, the observed trends suggest a consistent investment strategy coupled with a gradual decline in depreciation, resulting in a higher ratio of capital expenditures to depreciation. This warrants further investigation to understand the underlying drivers of these changes and their potential impact on future financial performance.

Analysis of Optum Health segment capital expenditures relative to depreciation reveals a generally increasing trend over the examined period, with some fluctuation. Purchases of property, equipment, and capitalized software consistently increased from 2021 to 2023, before experiencing a slight decrease in 2024 and then increasing again in 2025. Depreciation and amortization also exhibited a consistent upward trend throughout the period.

Purchases of Property, Equipment and Capitalized Software

Expenditures on property, equipment, and capitalized software increased from US$791 million in 2021 to US$1,199 million in 2023, representing a 51.1% increase over the two-year period. A decrease to US$1,008 million was observed in 2024, followed by a further increase to US$1,237 million in 2025. This suggests continued investment in the segment, with a temporary moderation in 2024.

Depreciation and Amortization

Depreciation and amortization expenses increased steadily from US$818 million in 2021 to US$1,211 million in 2025. This consistent increase aligns with the growing asset base resulting from the capital expenditures. The growth rate slowed slightly in 2024, mirroring the decrease in capital expenditures.

Segment Capital Expenditures to Depreciation

The ratio of segment capital expenditures to depreciation began at 0.97 in 2021, indicating that capital expenditures were slightly less than depreciation expense. The ratio increased to 1.06 in 2022 and 1.13 in 2023, suggesting increasing investment outpacing depreciation. A decrease to 0.90 was noted in 2024, likely due to the lower capital expenditure level that year. The ratio recovered to 1.02 in 2025, indicating a return to investment levels exceeding depreciation. The fluctuations suggest a dynamic investment strategy responsive to operational needs and opportunities.

Overall, the segment demonstrates a pattern of consistent investment, with capital expenditures generally exceeding depreciation, indicating a growing asset base. The slight dip in 2024 appears to be a temporary adjustment, with investment resuming an upward trajectory in 2025.

Analysis of segment capital expenditures to depreciation for Optum Insight reveals a fluctuating relationship between investments in long-term assets and the associated expense recognition over the five-year period. Purchases of property, equipment, and capitalized software demonstrate an overall increasing trend, while depreciation and amortization also generally increase, though at a varying pace.

Purchases of Property, Equipment and Capitalized Software

The level of purchases increased from US$567 million in 2021 to US$698 million in 2022, representing a 23.0% increase. Further growth was observed in 2023, reaching US$974 million, a 39.8% increase from the prior year. This growth continued into 2024, with purchases reaching US$1,291 million, a 32.5% increase. A slight decrease is noted in 2025, with purchases totaling US$1,170 million, representing a 9.4% decline from 2024. This suggests a period of substantial investment followed by a moderate pullback.

Depreciation and Amortization

Depreciation and amortization expenses rose from US$684 million in 2021 to US$841 million in 2022, a 23.0% increase. Growth continued to US$1,229 million in 2023, a 46.2% increase. The rate of increase slowed in 2024, with expenses reaching US$1,294 million, a 5.3% increase. Further growth is observed in 2025, with expenses totaling US$1,422 million, a 9.9% increase. The consistent increase in depreciation and amortization reflects the ongoing utilization of previously invested assets.

Segment Capital Expenditures to Depreciation

The ratio of segment capital expenditures to depreciation remained relatively stable at 0.83 in both 2021 and 2022. A slight decrease to 0.79 was observed in 2023, indicating that depreciation expense was growing at a faster rate than capital expenditures. A significant increase occurred in 2024, with the ratio reaching 1.00, suggesting that capital expenditures equaled depreciation expense. The ratio decreased slightly in 2025 to 0.82. The fluctuations suggest a dynamic relationship between investment and expense recognition, with 2024 representing a period where investments kept pace with the depreciation of existing assets.

Overall, the segment demonstrates a pattern of increasing investment in long-term assets, coupled with a corresponding rise in depreciation and amortization. The capital expenditures to depreciation ratio indicates periods of both investment outpacing depreciation and vice versa, suggesting a responsive capital allocation strategy.

Analysis of segment capital expenditures to depreciation for the observed period reveals a generally stable relationship, with some fluctuation. Purchases of property, equipment and capitalized software demonstrate an increasing trend overall, while depreciation and amortization consistently increased year-over-year. The resulting ratio, segment capital expenditures to depreciation, exhibits a relatively narrow range.

Purchases of Property, Equipment and Capitalized Software

Purchases began at US$301 million in 2021 and increased to US$308 million in 2022. A further increase to US$347 million was noted in 2023, followed by a more substantial rise to US$419 million in 2024. The final year observed, 2025, shows a slight decrease to US$399 million, though remaining above the 2021 and 2022 levels.

Depreciation and Amortization

Depreciation and amortization experienced consistent growth throughout the period. Starting at US$597 million in 2021, it rose to US$643 million in 2022, US$696 million in 2023, US$793 million in 2024, and finally reached US$845 million in 2025. This consistent increase suggests a growing asset base subject to depreciation.

Segment Capital Expenditures to Depreciation

The ratio of segment capital expenditures to depreciation began at 0.50 in 2021, decreased slightly to 0.48 in 2022, and then returned to 0.50 in 2023. A peak of 0.53 was observed in 2024, before declining to 0.47 in 2025. This indicates that, while investment in capital assets is occurring, the rate of investment relative to the existing depreciable asset base is not dramatically changing. The ratio remains consistently around one-half, suggesting a relatively balanced approach to asset renewal and expansion.

The observed fluctuations in the ratio are likely influenced by the differing growth rates of capital expenditures and depreciation. While both increased, the larger percentage increase in capital expenditures in 2024 drove the ratio higher, and the comparatively smaller increase in capital expenditures in 2025 resulted in a decrease.